POMPEYO CHAVEZ: Open Payments
NPI 1821292426 · BASTROP, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,808 in 71 payments from 17 companies in 2025. Trend: 2023 $1,832 · 2024 $1,720 · 2025 $1,808
Food & beverage: $1,808
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $260 |
| Corcept Therapeutics | 6 | $238 |
| Amgen Inc. | 9 | $203 |
| Abbott Laboratories | 4 | $197 |
| Novo Nordisk Inc | 6 | $193 |
| Shockwave Medical, Inc | 1 | $176 |
| AstraZeneca Pharmaceuticals LP | 4 | $162 |
| GlaxoSmithKline, LLC. | 13 | $140 |
| Otsuka America Pharmaceutical, Inc. | 1 | $77 |
| ABBVIE INC. | 3 | $57 |
Products named: Korlym, PROCLAIM, ZEPBOUND, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, REPATHA, AIRSUPRA, TRELEGY ELLIPTA, Ozempic.
Industry payments across TX — which companies pay providers there.
